A boutique firm for patient-centric research services and innovative clinical design to serve genetic diseases and personalized medicine such as gene therapies, genomics and rare diseases.

On March 1st, 2021, iTakeControl joined Red Nucleus and expands its platform and offerings globally.

Read the press release

iTakeControl enables new patient-centric R&D approaches in genomic research, gene therapy, rare and personalized medicine with our services, technology, and operational expertise.

Prospective Clinical Trials
Real World Evidence
Strategy and Governance

Why iTakeControl?

We have a fully integrated and comprehensive platform that enables you to quickly customize a mobile health solution for Real World Disease Management, Clinical Trial Management and R&D Management.


Supplement your team with strategic insight and innovative program management in a collaborative approach with your internal clinical and compliance teams for program value and research gaps.


Don’t just “build a survey” or build a “form.” Design the right mobile experience for unique disease or condition progression.


Extend your team with experienced biotech industry team members with digital strategy, GxP clinical process, and UX/UI experts.

“It’s a rapidly changing environment. We launched iTakeControl to enable biopharma to navigate these changes and feel confident in launching new digital research and training programs. We’re here because we want to see new data, faster research, and high quality training in the hands of patients and industry professionals alike.”

Dalia El-Sherif, Co-founder & Board Member


Schedule a Demo